The resources on this page are continuously updated to reflect the most recent state and federal guidance, as well as Missouri-specific resources.

COVID-19 Dashboards

The Missouri Hospital Association, in partnership with various state agencies, engaged in development of COVID-19 dashboards to assist local, regional and state decision-makers. Available dashboards include an interactive monitoring dashboard, regional and statewide dashboards, and state and national maps.

Latest Updates

MHA: Statement From MHA President And CEO On Mandatory Vaccination Policies (6/15/21)
HHS: HHS Issues Revised Notice of Reporting Requirements and Reporting Timeline for Recipients of Provider Relief Fund Payments (6/11/21)
FDA: FDA Extends Expiration Dates For Johnson & Johnson COVID-19 Vaccine (6/10/21)
Moderna: Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States (6/10/21)
CMS: Biden Administration Continues Efforts to Increase Vaccinations By Bolstering Payments for At-Home COVID-19 Vaccinations for Medicare Beneficiaries (6/9/21)
CDC: Increasing Access to Vaccination Opportunities: COVID-9 Vaccination Upon Discharge from Hospitals, EDs and Urgent Care Facilities (6/4/21)
NIH: How COVID-19 Can Lead to Diabetes (6/8/21)
U.S. District Court for the Southern District of Texas: Texas Court Denies Relief From Vaccine Mandate (6/7/21)
DHSS: Missouri Plain Language Guide for People with Disabilities, their Families and Caregivers (6/7/21)
HHS: COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting (6/10/21)
CDC: Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults (5/28/21)
EEOC: What You Should Know About COVID-19 and the ADA, the Rehabilitation Act, and Other EEO Laws (5/28/21)

View MHA’s COVID-19 update with recent developments, resources and information.

Fill out the online form to receive this daily update in your inbox.

Media Library

View the latest COVID-19 Resources

Explore COVID-19

Click to view

adult daughter embraces her older parents

Sample Policies & Forms

Testing, Reporting & Treatment

Vaccine Updates

group of doctors and nurses heading towards a patient

Workforce

MHA Contacts

Leslie Porth | Senior Vice President of Strategic Quality Initiatives | 573-893-3700, ext. 1305
Jackie Gatz | Vice President of Safety and Preparedness | 573-893-3700, ext. 1330

MHA Resources

Guidance

DESE: Guidance for Assessing COVID-19 Exposures and Defining Close Contacts in a School Setting (Nov. 12, 2020)
- DHSS, DESE: Missouri School Reopening & Operating Guidance Frequently Asked Health-Related COVID-19 Questions
DESE: COVID-19: Contact Tracing in Schools | Algorithms | FAQs (August 7, 2020)
DHSS: Missouri Guidance on Reopening of Long-Term Care Facilities (July 7, 2020)
CMS: Hospital Visitation – Phase II Visitation for Patients who are COVID-19 Negative (June 26, 2020)
ASPR TRACIE: Healthcare System Considerations for Resumption of Services during COVID-19
CDC: COVID-19 Pathways to Recovery (June 11, 2020)
CMS: Recommendations for Re-opening Facilities to Provide Nonemergent Non-COVID-19 Healthcare (June 8, 2020)
CMS: Guide for Patients To Resume In-person Health Care
CDC: Support for States, Tribes, Localities and Territories
CDC: CDC Activities and Initiatives Supporting the COVID-19 Response and the President’s Plan for Opening American Up Again (May 2020)
CMS: Nursing Home Reopening Recommendations for State and Local Officials | FAQs (May 18, 2020)
CDC: Checklists to assist employers in making reopening decisions during the COVID-19 pandemic
AHA: COVID-19 Pathways to Recovery: Considerations and Resources to Guide Hospital and Health Systems (May 2020)
CMS: Recommendations for Reopening Facilities to Provide Nonemergent COVID-19 Health Care: Phase 1 (April 19, 2020)
- AHA: Special Bulletin (April 20, 2020)
ACS, ASA, AORN, AHA: Joint Statement: Roadmap for Resuming Elective Surgery after COVID-19 Pandemic (April 17, 2020)
Trump Administration: Guidelines for Opening Up American Again (April 15, 2020)

MHA Contact

Daniel Landon | Senior Vice President of Governmental Relations | 573-893-3700, ext. 1349

State

Federal

Dept. of Treasury: U.S. Department Of Treasury Releases Details About ARPA State And Local Fiscal Recovery Funds | Fact Sheet (May 10, 2021)
HHS: HHS Announces $250 Million from American Rescue Plan to Develop and Support a Community-Based Workforce to Increase COVID-19 Vaccinations in Underserved Communities (May 4, 2021)
HHS: HHS Announces Nearly $1 Billion from American Rescue Plan for Rural COVID-19 Response (May 4, 2021)
HHS: HHS Extends Public Health Emergency (April 21, 2021)
Biden Administration: Biden Administration Announces Historic $10 Billion Investment to Expand Access to COVID-19 Vaccines and Build Vaccine Confidence in Hardest-Hit and Highest-Risk Communities (March 25, 2021)

Waivers

MHA developed a spreadsheet to track issues and pending waivers of state and federal regulatory requirements of interest to hospitals. The document will be updated regularly as additional waivers are requested or granted.

VIEW THE waivers SPREADSHEET

Also available is a compendium of licensure waivers for nurses, physicians and pharmacists, as well as a CMS resource that lists waivers and flexibilities by provider type.

DHSS: Waivers Terminated and Continued During COVID-19 Emergency (April 21, 2021)
DHSS: Waiver of Requirement to Register with DHSS Bureau of Narcotics and Dangerous Drugs (Jan. 20, 2021)
CMS: New Platform for Submissions of 1135 Waiver Requests and Inquiries – Go Live (Jan. 11, 2021)
CMS: CMS Grants Additional Waivers To Small Rural And Sole Community Hospitals (Dec. 23, 2020)
Missouri Board of Pharmacy: COVID-19 Waiver Update and Extensions (June 22, 2020)
Missouri Board of Pharmacy: COVID-19 Waiver Update and Extensions (June 5, 2020)
CMS: COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (May 15, 2020)
DCI: Extension Of Bulletin 20-07 – Services Provided Via Telehealth (May 15, 2020)
CMS: Section 1135 Waiver Flexibilities – Missouri Coronavirus Disease 2019 (First Request) (May 14, 2020)
Missouri Board of Pharmacy: COVID-19 Statutory/Rule Waivers (April 29, 2020)
Missouri DHSS: Important Information Regarding 1135 Waiver Implementation For PASRR (April 22, 2020)
MHD: 1135 Waiver Implementation for PASRR (April 22, 2020)
MHD: Home Health Waivers (April 17, 2020)
Missouri DHSS: Notification of Potential Exposure to COVID-19 for First Responders (April 13, 2020)
CMS: FAQs About FFCRA and CARES Act Implementation (April 11, 2020)
Missouri DHSS: Home Health and Hospice APRNs and PAs (April 9, 2020)
DCI: Waivers To Increase Access to Delivery of Health Care by APs and PAs (April 6, 2020)
Missouri DHSS: Waivers Related to Trauma, Stroke, and STEMI Designated Hospitals (April 2, 2020)
Missouri DHSS: Nurse Assistant Training Program (April 3, 2020)
Missouri DHSS: Hospital Inspections and Investigations (April 2, 2020)
Missouri DHSS: Waivers Related to Advance Practice Registered Nurses (April 1, 2020)
Missouri DHSS: Waivers Related to the Bureau of Narcotics & Dangerous Drugs (March 31, 2020)
Missouri DHSS: Deadline for Hospital Annual Survey Data (March 27, 2020)
CMS: Blanket Waivers of Section 1877(g) of the Social Security Act (March 30, 2020)
CMS: Section 1135 Flexibilities Requested by MHA on March 16 (March 26, 2020)
CMS: Section 1135 Waiver Flexibilities — Missouri COVID-19 (March 25, 2020)
Missouri DCI: Assistance to Policyholders Impacted by COVID-19 (March 21, 2020)
Missouri DHSS: Hospital Licensure Regulations (March 20, 2020)
Missouri Board of Pharmacy: COVID-19 Emergency Rule Updates (March 20, 2020)
CMS: COVID-19 Emergency Declaration Health Care Providers Fact Sheet (March 13, 2020)

Waiver Requests

MHA developed guidance for hospitals to develop waiver requests specific to their unique needs.

MHA Requests Extension Of Waivers (March 17, 2021)
MHA Requests Survey Waiver From CMS (Dec. 2, 2020)
MHA Submits Additional Waiver Requests (Nov. 17, 2020)
MHA request to DHSS on UAP, protections for first responders, TCD and CoPs (March 31, 2020)
MHA letter to DHSS on annual hospital licensing survey, annual data survey, TCD and federal support (March 25, 2020)
Missouri DSS requests CMS relax several requirements through a 1135 waiver (March 20, 2020)
MHA waiver request to Gov. Parson (March 18, 2020)
MHA letter to DHSS Addressing Daycare Shortages (March 16, 2020)
Waiver request under Section 1135 to CMS | MHA letter to Gov. Parson (March 16, 2020)

MHA Contact

Daniel Landon | Senior Vice President of Governmental Relations | 573-893-3700, ext. 1349

Congressional Action

MHA Contacts

Alison Williams | Vice President of Clinical Quality Improvement | 573-893-3700, ext. 1326
Keri Barclay | Manager of Clinical Preparedness | 573-893-3700, ext. 1407
Jessica Stultz | Director of Clinical Quality | 573-893-3700, ext. 1391

Clinical Guidance or Standards

CDC: Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing (Dec. 2, 2020)
CDC: Revises Definition Of Close Contacts In New Guidance (Oct. 21, 2020)
MHA: COVID-19 Clinical Operations FAQs (updated May, 2020)
FDA: Information for Health Care Facilities and Providers on “in-use time” (Aug. 4, 2020)
DHSS: Discontinuation of Isolation for Persons with COVID-19 (July 27, 2020)
CDC: Duration of Isolation and Precautions for Adults with COVID-19 (July 22, 2020)
CDC: CDC Updates, Expands List of People at Risk of Severe COVID-19 (June 25, 2020)
AHA: Addressing Emotions on the Front Lines (May 2020)
AHA: Proactive Conversations that Support Providers and Patients (April 2020)
National Academies: Rapid Expert Consultations on the COVID-19 Pandemic (March 14 – April 18, 2020)
AHA: Caring with Limited Resources During COVID-19 (April 29, 2020)
NLM: LitCovid Literature Hub
CMS: Trump Administration Champions Reporting of COVID-19 Clinical Trial Data through Quality Payment Program, Announces New Clinical Trials Improvement Activity (April 20, 2020)
AHA: Interim Guidance for Basic and Advanced Life Support in Adults, Children and Neonates with Suspected or Confirmed COVID-19 | eLearning Course
SCCM: Critical Care Education and Resources for the Non-ICU Clinician
AHA: COVID-19 Cardiovascular Disease Registry
Example Algorithms for COVID-19 Clinical Care:
- COVID-19 Triage Worksheet
- Recommendations on the Initial Management of Hypoxic COVID-19 Patients
AHA: Caring with Limited Resources During the COVID-19 Crisis: A Compilation of Resources for Your Team (April 1, 2020)
HHS ASPR Tabletop Exercises:
- Fatality Management Tabletop Exercise Situational Manual and PowerPoint
- Pandemic Contagion Private Sector Tabletop Exercise Materials
SAMHSA: Repository of Resources and Information Related to COVID-19
UW Medicine: COVID-19 Ambulatory Practice Resource Site

Behavioral Health

MHA: You’re Not Alone — Confronting COVID-19 And The Holidays (Dec. 21, 2020)
AHA: Stress and Coping Resources
KFF: The Implications of COVID-19 for Mental Health and Substance Use (April 21, 2020)
AACN: Facing Moral Distress During the COVID-19 Crisis (April 8, 2020)
AACN: COVID-19: How Nurse Managers Can Mitigate Nurse PTSD (April 3, 2020)
Mental Health Academy: Resources for Mental Health Providers and Front-line Workers Assisting with the Global COVID-19 Crisis

Education

Mental Health Academy: Resources for Mental Health Providers and Front-line Workers Assisting with the Global COVID-19 Crisis
TJC: Preparing Behavioral Health Organizations for Coronavirus (March 20, 2020) — Recording

End-of-Life and Palliative Care Resources

Infection Control Resources

CDC: Updated Healthcare Infection Prevention and Control Recommendations in Response to COVID-19 Vaccination (April 27, 2021)
APIC: Airborne Transmission: The Basics and Not so Basic — Podcast (December 2020)
CDC: Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2 (Nov. 10, 2020)
CDC: Reduce Risk from Surfaces — A Key Component of Environmental Cleaning
CDC: Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the COVID-19 Pandemic (Nov. 4, 2020)
CDC: How COVID-19 Spreads
FDA: FDA updates on hand sanitizers consumers should not use (Aug. 18, 2020)
FDA: FDA Updates on Hand Sanitizers with Methanol
SEAN: Encouraging Adoption of Protective Behaviors to Mitigate The Spread of COVID-19: Strategies for Behavior Change
EPA: EPA Approves First Surface Disinfectant Products Tested on the SARS-CoV-2 Virus (July 6, 2020)
CDC: Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Health Care Settings (April 13, 2020)
CDC: Public Health Recommendations for Community-Related Exposure (March 30, 2020)
CDC: Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (March 23, 2020)
CDC: Health Care Infection Prevention and Control FAQs for COVID-19
CDC: Health Care Respiratory Protection Resources
CDC: Health Care Supply of Personal Protective Equipment
Interim Cleaning Recommendations for Facilities Housing Persons Under Quarantine for COVID-19 (Feb. 29, 2020)

LTCF and Nursing Home Guidance

Treating Pregnant Women or Children

CDC: Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy (Nov. 6, 2020)
CDC: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status (Nov. 6, 2020)
AAP: Interim Guidance on Children’s Emotional and Behavioral Health During the COVID-19 Pandemic; Child Care Interim Guidance is Updated (Oct. 26, 2020)
CDC: COVID-19–Associated Multisystem Inflammatory Syndrome in Children (Aug. 7, 2020)
AAP: Management of Infants Born to Mothers with Suspected or Confirmed COVID-19 (July 22, 2020)
AHA: Maternal and Child Health During COVID-19 (July 2020)
CDC: If You Are Pregnant, Breastfeeding, or Caring for Young Children (June 25, 2020)
CDC | DHSS: MIS-C Case Report Forms Available
CDC: Evaluation and Management Considerations for Neonates at Risk for COVID-19
CDC | DHSS: Immediate Reporting Required for Multisystem Inflammatory Syndrome in Children
American Journal of Perinatology: General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic
CDC: Interim Guidance to Prevent Mother-to-Child Transmission of Hepatitis B Virus During COVID-19-related Disruptions in Routine Preventive Services
SMFM: COVID-19 and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know (April 11, 2020)
SMFM: Changes in Pregnancy and Maternity Care Advice for Women and Their Families (April 8, 2020)
UCSF: PRIORITY: Pregnancy Coronavirus Outcomes Registry
CMQCC: COVID-19 Resources for Maternal and Infant Health
CMQCC Webinar: Preparing your Maternal and Neonatal Units to Respond to COVID-19 (March 24, 2020)
Management of Obstetric COVID-19 Cases in the Operating Room (March 22, 2020)
AJOG: Maternal-Fetal Medicine Guidance for COVID-19 (March 19, 2020)
ACOG and SMFM: Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed COVID-19 (March 2020)

COVID-19 Playbook

MHA would like to thank the Mercy Hospital System for the alternate specimen collection site playbook, which is linked below. This document is provided as a draft to allow our hospital partners to update/revise these documents to meet your needs. During these times, there are frequent revisions & recommendations provided to us as the COVID-19 situation evolves. We caution you to be mindful of those frequent updates as current knowledge and clinical standards evolve.

MHA Contacts

Jackie Gatz | Vice President of Safety and Preparedness | 573-893-3700, ext. 1330
Mat Reidhead | Vice President of Research and Analytics | 573-893-3700, ext. 1331
Dave Dillon | Vice President of Public and Media Relations | 573-893-3700, ext. 1311

Data Submission to TeleTracking

Missouri hospitals now must report COVID-19 data on bed capacity, utilization, personal protective equipment and in-house laboratory testing to the HHS TeleTracking portal daily by 4 p.m., including weekends.

HHS: COVID-19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting (June 10, 2021)
MHA: Data Submission to TeleTracking Fact Sheet (Sept. 2, 2020)
COVID-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory and Acute Care Facility Data Reporting
HHS Memo: Hospital Administrator Guidance
Recording: July 15 MHA Member Call
Recording: July 22 MHA Member Call

MHA Reports

COVID-19 Data Insights

Age Drift in Positive COVID-19 Testing Moves Toward Younger Missourians (June 26, 2020)

The Disproportionate Impact of COVID-19 on Black and African American Communities in the St. Louis Region

While age and the presence of comorbid conditions are significant predictors of morbidity and mortality among individuals contracting the COVID-19 virus, race is emerging as a critical risk factor as the number of cases and available data continue to expand.

Research — published by MHA and other key stakeholders — on the influence of COVID-19 among St. Louis-area communities finds the region’s Black and African American residents have been especially hard hit by the crisis. The report concludes with recommendations for future research and action steps that enable prevention, mitigation and healing.

READ THE REPORT

MHA Contact

Daphney Partridge | Vice President of Education | 573-893-3700, ext. 1333

Upcoming Calls/Education

On-Demand Education

Recordings for CMS National Stakeholder Calls

CMS has been hosting regular calls to keep stakeholders updated on COVID-19 efforts. Recordings and transcripts from the calls are available online.

Past Webinars

MHA: COVID-19 Lessons Learned from Missouri Hospitals
ASPR TRACIE: Crisis Standards of Care and COVID-19: What’s Working and What Isn’t — PowerPoint | Recording
AHA: TeamSTEPPS for the COVID-19 Crisis Video Series
COVID-19 Show-Me ECHO (March 23, 2020) — Recording
CDC COCA: Outbreak of 2019 Novel Coronavirus — Interim Guidance for Clinicians (Jan. 31, 2020) — Recording

MHA Contacts

Leslie Porth | Senior Vice President of Strategic Quality Initiatives | 573-893-3700, ext. 1305
Jackie Gatz | Vice President of Safety and Preparedness | 573-893-3700, ext. 1330
Andrew Wheeler | Vice President of Federal Finance | 573-893-3700, ext. 1336

MHA Resources

Financial Resources

MHA Resources

COVID-19 Vaccine Administration Finance Reference Sheet (Feb. 11, 2021)
The Financial Toll of COVID-19 on Missouri Hospitals (June 5, 2020)
COVID-19 and Missouri Hospital Finances (May 8, 2020)
Advocacy and Policy Developments to Provide Financial Assistance to Hospitals

Resources

HHS: HHS Issues Revised Notice of Reporting Requirements and Reporting Timeline for Recipients of Provider Relief Fund Payments (June 11, 2021)
HHS: HHS Launches New Reimbursement Program for COVID-19 Vaccine Administration Fees not Covered by Insurance (May 3, 2021)
CRS: Medicare Accelerated and Advance Payments and COVID-19: Frequently Asked Questions (April 8, 2021)
FEMA: FEMA Offers COVID-19 Funeral Assistance
DHSS: Missouri’s Rural Hospitals Eligible for CARES Act Relief Funds (March 16, 2021)
FEMA: Coronavirus Pandemic: Medical Care Eligible for Public Assistance (March 15, 2021)
SBA: Paycheck Protection Program Loans FAQs | First Draw | Second Draw (March 12, 2021)
CRS: COVID-19 Vaccine: Financing for its Administration (Feb. 19, 2021)
CMS: FAQs For Billing Medicare FFS (Updated Dec. 8, 2020)
CMS: Coverage of Monoclonal Antibody Products to Treat COVID-19 (December 2020)
SEMA: Public Assistance Program
CMS: Medicare Accelerated and Advance Payments Program COVID-19 Public Health Emergency Payment Data
HHS: CARES Act Provider Relief Fund FAQs | MHA Version
HHS: HHS Expands Relief Fund Eligibility and Updates Reporting Requirements (Oct. 22, 2020)
HHS: Providers May Use Remaining PRF Funds To Cover Lost Revenue (Oct. 22, 2020)
AICPA: Summary of Uniform Guidance Applicability for New COVID-19-Related Federal Programs | PYA Insights (July 28, 2020)
HHS: HHS To Begin Distributing $10 Billion in Additional Funding to Hospitals in High Impact COVID-19 Areas (July 17, 2020)
HRSA: Provider Relief Fund: Medicaid and CHIP Provider Distribution Fact Sheet
HHS: HHS Announces Over $4 Billion in Additional Relief Payments to Healthcare Providers Impacted by the Coronavirus Pandemic (July 10, 2020)
DOL, HHS, DOT: FAQs About FFCRA and CARES Act Implementation Part 43 (June 23, 2020)
HHS: Relief Funds Available for Medicaid and CHIP Providers (June 9, 2020)
HHS: Relief Funds Available for Safety Net Hospitals (June 9, 2020)
CMS: FAQs For Billing Medicare FFS
CMS: Fact Sheet For Services Provided At Alternative Care Sites
SBA: Paycheck Protection Program Loan Forgiveness Application
Spencer Fane: Retroactive Change in Distribution Methodology for Provider Relief Funds May Trigger Refunds (May 8, 2020)
HRSA: COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing and Treatment of the Uninsured (April 28, 2020)
HHS: HHS Launches COVID-19 Uninsured Program Portal (April 27, 2020)
HHS: HHS Announces CARES Act Funding Distribution to States and Localities in Support of COVID-19 Response (April 23, 2020)
Spencer Fane: Public Health and Social Services Emergency Fund Payments (April 13, 2020)
FCC: COVID-19 Telehealth Program Application Portal Will Open Monday (April 10, 2020)
Independent Sector: CARES Act: How to Apply for Nonprofit Relief Funds
CMS: MLN Connects Special Edition on COVID-19 payment and policy guidance (April 7, 2020)
Tidal Basin Recording: Filing for FEMA Disaster Recovery (April 2, 2020)
- Tidal Basin is a consulting firm that helps organizations with disaster preparedness and disaster recovery with FEMA. This webinar provides details about the filing process and covered costs. Note: The deadline to file a Request for Public Assistance is Saturday, April 25.
Missouri Foundation for Health: COVID-19 Updates and Federal Funding Information (April 1, 2020)
Wisconsin Physician Services: Accelerated Payment Request Certification – COVID-19 (March 31, 2020)
FEMA: COVID-19 Pandemic: Eligible Emergency Protective Measures (March 19, 2020)

Tracking COVID-19 Expenses

Federal funding may become available for COVID-19-related expenses through the Federal Emergency Management Agency. Hospitals that wish to apply for these funds will be well-served to ensure that those expenses are appropriately documented per FEMA standards.

As a best practice, some hospitals are setting up COVID-19 Response Cost Centers. This ensures that hospitals have expenses tracked and sufficiently documented. Hospitals are reporting that they are electronically assigning staff time and wages, supplies and equipment purchases used to treat patients. Such practices help quickly assess the cost of COVID-19 and substantiate future possible reimbursement opportunities.

The following Hospital Incident Command System forms may be helpful in identifying and recording expenses.

Hospital Preparedness Resources

ASPR TRACIE: Hospital Operations Toolkit for COVID-19
ASHE: Life Safety/Staff Safety Tips
CDC: COVID-19 Surge Calculator
CISA: Resources and assistance to combat cyber threats related to COVID-19
FEMA: Coronavirus Emergency Management Best Practices
FEMA Healthcare Resilience Task Force: COVID-19 Hospital Resource Package
ASPR TRACIE: COVID-19 Resources for Health Care Planning
H-ISAC, RiskRecon: Free Cybersecurity Assessments Through Dec. 31
CDC: Implementation of Mitigation Strategies for Communities with Local COVID-19 Transmission
CDC: Comprehensive Hospital Preparedness Checklist for COVID-19

Telehealth Guidance

CMS: Trump Administration Drives Telehealth Services in Medicaid and Medicare | List of Telehealth Services (Oct. 14, 2020)
CRS: Medicaid Telehealth Policies in Response to COVID-19 (Oct. 9, 2020)
CMS: Services Delivered via Telehealth Among Medicaid & CHIP Beneficiaries During COVID-19
HHS: Medicare Beneficiary Use of Telehealth Visits: Early Data from the State of the COVID-19 Pandemic (July 28, 2020)
HHS: HHS Awards $15 Million to Support Telehealth Providers During the COVID-19 Pandemic (May 13, 2020)
CMS: Medicare Coverage and Payment of Virtual Services (May 8, 2020)
AHRQ: How to Obtain Consent for Telehealth | Sample Telehealth Consent Form
DHS, CISA: Telework Guidance and Resources
HHS: HHS Awards $20 Million to Combat COVID-19 Pandemic through Telehealth (April 30, 2020)
AHA, NQF: Redesigning Care: A How-to Guide for Hospitals and Health Systems Seeking to Implement, Strengthen and Sustain Telebehavioral Health
CMS: State Medicaid & CHIP Telehealth Toolkit: Policy Considerations for States Expanding Use of Telehealth
MTN and MOREnet: Complimentary Zoom licenses to local public health agencies, RHCs, FQHCs and CAHs
CMS: FAQs on Telehealth and HIPAA During COVID-19 (March 23, 2020)
CMS: End-Stage Renal Disease Provider Telehealth and Telemedicine Toolkit (March 23, 2020)
National Consortium of Telehealth Resources Centers: COVID-19 Telehealth Toolkit (March 18, 2020)
CMS: General Provider Telehealth and Telemedicine Toolkit

Education

SPRC: Treating Suicidal Patients During COVID-19: Best Practices and Telehealth — Recording & PowerPoint
Understanding Telehealth Updates for COVID-19 (April, 13, 2020) — Recording

Other Guidance or Standards

Education

MHA Contacts

Jane Drummond | General Counsel and Vice President of Legal Affairs | 573-893-3700, ext. 1328
Sarah Willson | Vice President of Clinical and Regulatory Affairs | 573-893-3700, ext. 1304

MHA Guidance Documents

Expedited Licensing Pathways Available For Health Care Workers In Response To COVID-19
COVID-19 Vaccine Liability Protections Fact Sheet (Jan. 5, 2021)
EEOC Vaccine Guidance (Dec. 22, 2020)
Staffing Rates and the Law on Price Gouging (Dec. 18, 2020)
COVID-19 Leave Obligations (Sept. 15, 2020)
COVID-19 Legal Resource Toolkit (April 27, 2020)
Guidance for hospitals to develop waiver requests specific to their unique needs (March 19, 2020)
Guidance for Cancellation of Elective Surgeries and Other Procedures (March 17, 2020)
COVID-19 and Your Workforce (March 2020)
COVID-19 and EMTALA (March 2020)
- Customizable signage is available for hospitals considering alternate testing locations, hospital-specific hotlines or working to manage patients who may arrive at the hospital for treatment of COVID-19.

Regulatory and Compliance Calls

Resources

EEOC: What You Should Know About COVID-19 and the ADA, the Rehabilitation Act, and Other EEO Laws (May 28, 2021)
CMS: Hospital Mandatory COVID-19 Reporting Enforcement Workflow
TJC: Further Clarification on Resumption of Survey and Review Activities (July 1, 2020)
CMS: 2020 Quality Payment Program Exception Applications Fact Sheet
OIG: FAQs – Application of OIG’s Administrative Enforcement Authorities to Arrangements Directly Connected to COVID-19 (May 14, 2020)
CMS: FAQs for Hospitals and CAHs Regarding EMTALA
CMS: New and Expanded Flexibilities for RHCs and FQHCs During the COVID-19 Public Health Emergency (April 17, 2020)
CMS: CMS Increases Medicare Payment for High-Production Coronavirus Lab Tests (April 15, 2020)
Missouri DHSS: Reporting COVID-19 Cases (April 6, 2020)
Missouri DHSS: Health Care Worker Letter Related to the “Stay Home Missouri” Order (April 2, 2020)
FDA: FDA Authorizes Use of Battelle Decontamination System for N95 Respirators (March 28, 2020)
OSHA: Guidance on Preparing Workplaces for COVID-19 (March 2020)
Office for Civil Rights: COVID-19 and HIPAA: Disclosures to Law Enforcement, Paramedics, and Other First Responders and Public Health Authorities (March 26, 2020)
FDA: FDA Issues First Emergency Use Authorization for Point-of-Care Diagnostic (March 22, 2020)
FDA: FDA Provides More Regulatory Relief During Outbreak, Continues to Help Expedite Availability of Diagnostics (March 16, 2020)
CMS: CMS COVID-19 Emergency Declaration Health Care Providers Fact Sheet (March 13, 2020)
HHS: Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 public health emergency (March 19, 2020)
SAMHSA: COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance
CMS has issued several press releases regarding COVID-19. Visit its Newsroom for the latest updates.
- CMS Takes Action Nationwide to Aggressively Respond to Coronavirus National Emergency (March 13, 2020)
DVN-GL Healthcare Advisory Notice: Survey Plans in Light of COVID-19 (March 11, 2020)
TJC: Letter explaining survey activity amid COVID-19 (March 9, 2020)
Office for Civil Rights, U.S. DHSS BULLETIN: HIPAA Privacy and Novel Coronavirus (February 2020)

CMS QSO Memos

Updates to Long-Term Care Emergency Regulatory Waivers Issued in Response to COVID-19 (April 8, 2021)
Resuming Hospital Survey Activities Following 30-Day Restrictions (March 26, 2021)
Nursing Home Visitation (March 10, 2021)
Hospital Survey Priorities (Feb. 18, 2021)
Visitation at Intermediate Care Facilities for Individuals with Intellectual Disabilities and Psychiatric Residential Treatment Facilities (Feb. 10, 2021)
New Platform for Submissions of 1135 Waiver Requests and Inquiries – Go Live (Jan. 11, 2021)
CLIA Laboratories Surveyor Guidance for New and Modified CLIA Requirements Related to SARS-CoV-2 Test Result Reporting (Jan. 8, 2021)
Revised COVID-19 Focused Infection Control Survey Tool for Acute and Continuing Care (Dec. 30, 2020)
Providing Flexibility for Exceeding the 24-hour Time Frame for Patients in ASCs During the COVID-19 PHE (Dec. 30, 2020)
COVID-19 Infection Control for Psychiatric and Intermediate Care Facilities for Individuals with Intellectual Disabilities (Dec. 17, 2020)
CLIA CMS Locations and State Agency Remote Survey Guidance (Nov. 6, 2020)
Guidance Related to the Emergency Preparedness Testing Exercise Requirements (Sept. 28, 2020)
Interim Final Rule, CMS-3401-IFC, Updating Requirements for Reporting of SARS-CoV-2 Test Results by CLIA Laboratories, and Additional Policy and Regulatory Revisions in Response to the COVID-19 PHE (Aug. 26, 2020)
Enforcement Cases Held during the Prioritization Period and Revised Survey Prioritization (Aug. 17, 2020)
Nursing Home Five Star Quality Rating System Updates, Nursing Home Staff Counts, and FAQs (April 24, 2020)
Upcoming Requirements for Notification of Confirmed COVID-19 (or COVID-19 PUI) Among Residents and Staff in Nursing Homes (April 19, 2020)
Guidance for Processing Attestation Statements from ASCs Temporarily Enrolling as Hospitals During the COVID-19 Public Health Emergency (April 3, 2020)
CMS Guidance for Infection Control and Prevention of COVID-19 in Hospitals, Psychiatric Hospitals and CAHs: FAQs, Considerations for Patient Triage, Placement, Limits to Visitation and Availability of 1135 Waivers (March 30, 2020)
CMS EMTALA Requirements and Implications Related to COVID-19 (March 30, 2020)
Clinical Laboratory Improvement Amendments Laboratory Guidance During COVID-19 Public Health Emergency (March 26, 2020)
Prioritization of Survey Activities: QSO-20-20-ALL provides guidance for all state survey agency directors on the new prioritization of survey activity and includes the revised self-assessment checklist for infection control for acute providers. (March 23, 2020)
Guidance for Infection Control and Prevention of COVID-19 in Nursing Homes (March 13, 2020)
CMS Suspension of Survey Activities (March 4, 2020)

MHA Contacts

Stacie Hollis | Manager of Emergency Preparedness/Coalition Administrative Liaison | 573-893-3700, ext. 1321
Jessica Stultz | Director of Clinical Quality | 573-893-3700, ext. 1391

Guidance

FDA: Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities (May 27, 2021)
FDA: FDA Recommends Transition from Use of Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities (April 9, 2021)
CDC: Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure (Feb. 19, 2021)
FDA: Using Ventilator Splitters During the COVID-19 Pandemic – Letter to Health Care Providers (Feb. 9, 2021)
FDA: FDA Import Alert For Alcohol-Based Hand Sanitizer From Mexico (Jan. 26, 2021)
CDC: Strategies for Optimizing the Supply of PPE
CDC: Strategies for Optimizing the Supply of N95 Respirators

Resources

Education

MHA Contact

Dave Dillon | Vice President of Public and Media Relations | 573-893-3700, ext. 1311

Coalition for Healthy Missouri Communities

The Coalition for Healthy Missouri Communities is a group of like-minded organizations uniting from all areas of industry in efforts to keep Missouri’s health care system stable, essential workers safe and Missouri’s businesses open.

The coalition released a statewide ad campaign about the importance of masking and social distancing. It is designed to encourage Missourians to use the tools available to safeguard themselves, their families and Missouri communities from COVID-19.

The campaign includes two TV spots, two radio spots, and digital and social media branded under a broad-based Coalition for Healthy Missouri Communities. Assets are available for download and distribution on the coalition website at www.healthymocommunities.com.

Digital Toolkits

COVID-19 & Delayed Care Digital Toolkit

Throughout the COVID-19 pandemic, health screenings and preventive procedures for cancer, heart disease, diabetes, well-child visits, substance use disorder and mental health dropped precipitously. To demonstrate the negative impact of delaying life-saving screenings and encourage Missourians to get their preventive health care back on track, MHA is launching a “COVID-19 and Delayed Care” digital campaign, which includes infographics and social media graphics.

Access the delayed care toolkit

Road to Reopening Communications Digital Toolkit

Don't delay necessary care. Missouri hospitals are prepared and ready for care 24/7.

As Missouri hospitals prepare to reopen following the COVID-19 emergency, MHA has created a variety of communications resources using the theme “Missouri Hospitals: Ready For You.” Along with facilitating a statewide campaign comprised of digital billboards, social media and digital advertising to help assure the public that Missouri’s hospitals are prepared, safe and ready to care, we’ve also created digital assets that hospitals can co-brand, as well as talking points and Missouri hospital statistics.

Access the reopening toolkit

Protect a Hero Digital Toolkit

To support front-line health care staff and encourage social distancing, MHA produced a Protect A Hero digital toolkit for hospital use. Using the message, “Protect a Hero. Be a Hero. Stay Home,” the toolkit includes graphics sized for email and web, as well as two options for a Facebook photo overlay.

To add a frame to your Facebook picture, go to your profile, tap “Update” on your profile picture, then tap “Add Frame.” Search for “MHA: Protect a Hero” to see two overlay options.

Access the hero toolkit

Mask Resources

Mask Up Missouri

To reduce the spread of COVID-19 and maintain the progress in reopening, a coalition of stakeholders are promoting “Mask Up Missouri” to educate Missourians on the benefits of mask wearing. The group released a printable poster and social images that individuals, organizations and businesses can use to promote the wearing of masks in public. A Spanish version of the poster also is available.

Access the mask up resources

Student Superheroes

MHA, the Missouri Department of Elementary and Secondary Education, and the Missouri School Boards’ Association released a poster and social images reminding students that they can use their own powers to defend against the virus in their schools and communities. Spanish versions of these resources also are available.

access the student resources

Social Images

Masks are still required in most medical facilities.

Customizable Signage

Visitor Reintroduction Signage

Visitor policies have changed signs - red, yellow, green

To support hospitals during reopening, MHA created resources to support transitioning visitor policies, including visual tools.

Access the resources

Customizable Signage

MHA produced a series of customizable signage and flyers related to COVID-19, including when patients should contact their health care provider, visitor restrictions and policies, closed entrances, effective handwashing, and infection prevention techniques.

access the signage

MHA Resources

Resources

MOStopsCOVID: COVID-19 Vaccine Digital Toolkit
AHA: Wear a Mask Campaign
Ad Council: COVID-19 Vaccine Education
CDC: Project Firstline
PrepareSTL Campaign: Local Health Organizations Partner to Reach Most Vulnerable During Coronavirus Crisis
- Website
- Flyers
- Poster
- PSA
NRHA: COVID-19 Communications Toolkit
HHS: COVID-19 Monoclonal Antibody Therapeutics Digital Toolkit

MHA Contacts

Dana Dahl | Vice President of Membership Services and Rural Initiatives | 573-893-3700, ext. 1314
Stephen Njenga | Director of Performance Measurement Compliance | 573-893-3700, ext. 1325

MHA Resources

Websites

Resources

DHSS: Missouri’s Rural Hospitals Eligible for CARES Act Relief Funds (March 16, 2021)
FMT: Innovations and Workforce Challenges for CAHs During COVID-19 (March 2021)
FMT: CAH Partnerships During the COVID-19 Pandemic (March 2021)
CMS: CMS Grants Additional Waivers To Small Rural And Sole Community Hospitals (Dec. 23, 2020)
NRHA: How health partnerships can help rural communities prep for COVID (August 21, 2020)
CMS: Rural Crosswalk: CMS Flexibilities to Fight COVID-19 (August 2020)
CDC: COVID-19 Response Health Equity Strategy (July 2020)
NRHC: COVID-19 Funding Sources Impacting Rural Providers (July 2020)
RHI Hub: Rural Health Care Surge Readiness
NRHC: COVID-19 Collection
CDC: Guidance and Resources for Rural Communities
RHV: The Future of Rural Value-Based Health Care And Surge Capacity (June 9, 2020)
ASPR TRACIE: Rural Health and COVID-19 Quick Sheet
AHA: Rural Case Studies: Rural Hospital Interventions for Coronavirus (COVID-19)
USDA: COVID-19 Federal Rural Resource Guide
U.S. Department of Agriculture Rural Development: COVID-19 Response

MHA Policy Templates

Transitional Care Resources

MHA, Leading Age Missouri, Missouri Health Care Association and the Department of Health and Senior Services, have collaborated to develop the following tools to be used when transferring patients from one care facility to another. Using guidance from the CDC and CMS, these forms capture pertinent information related to a patient’s COVID-19 status to expedite transfers, keep health care staff safe and informed, and reduce inappropriate testing requests prior to acceptance.

These tools should be:

completed by the health care team with the signature of the provider overseeing care
provided to the facility as part of the inquiry for discharge placement
used regardless of COVID-19 diagnosis while in the hospital
provided to EMS

DHSS can provide direction if a facility is refusing to take back a patient after transferring that patient to the hospital; however, DHSS cannot require a facility to accept new admissions. A facility may refuse new admissions for a variety of reasons, including an internal event or upon direction from the department. Hospitals can contact Shelly Williamson, shelly.williamson@health.mo.gov, or Tracy Niekamp, Tracy.Niekamp@health.mo.gov, with concerns related to a specific facility, or call 573-526-8524.

Visitor & Volunteer Sample Policies

MHA Screening and Visitors Guides

CoxHealth PFE Sample Forms and Resources

Resources

Missouri hospitals’ volunteer/auxiliary policies in response to COVID-19 (March 16, 2020)

MHA Contact

Keri Barclay | Manager of Clinical Preparedness/Coalition Administrative Liaison | 573-893-3700, ext. 1407

MHA Updates

Identification, Testing and Reporting

Effective March 25, hospital CEOs will receive a notification from AHA requesting a daily count of COVID-19 tests performed and positive results. It important to note that only hospitals who are performing these tests within their internal lab departments must report this data.

FDA: FDA Authorizes AI Armband For COVID-19 Screening (March 19, 2021)
FDA: FDA Authorizes First Fully At-Home COVID-19 Diagnostic Test (Dec. 15, 2020)
Regeneron: Regeneron Monoclonal Antibody Therapy Available | Casirivimab and Imdevimab Guidebook (November 2020)
FDA: FDA Authorizes First COVID-19 Test For Self-Testing At Home (Nov. 17, 2020)
NASEM: Advantages and Trade-offs of COVID-19 Diagnostic Tests, National Testing Strategies Examined in New Rapid Response to Government (Nov. 9, 2020)
DHSS: Update: Recommended Measures to Limit False Positive Results with COVID-19 Antigen Tests (Nov. 9, 2020)
FDA: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection (Nov. 6, 2020)
FDA: Potential for False Positive Results with Antigen Tests for Rapid Detection of SARS-CoV-2 – Letter to Clinical Laboratory Staff and Health Care Providers (Nov. 3, 2020)
HHS: Abbott BinaxNOW™ COVID-19 Ag Card Point of Care SARS-CoV-2 Diagnostic Test Fact Sheet
HHS: Trump Administration Makes Major Investment to Increase Availability of Fast Molecular POC Test (Oct. 13, 2020)
Abbot: Abbott Receives FDA EUA for its COVID-19 IGM Antibody Blood Test (Oct. 12, 2020)
NIH: NIH RADx Initiative Advances Six New COVID-19 Testing Technologies (Oct. 6, 2020)
NIH: NIH to Assess and Expand COVID-19 Testing for Underserved Communities (Sept. 30, 2020)
AP News: Feds to Ship Millions of Tests in Bid to Reopen K-12 Schools (Sept. 28, 2020)
CDC: Overview of Testing for SARS-CoV-2 (COVID-19) (Sept. 18, 2020)
FDA: SARS-CoV-2 Reference Panel Comparative Data (Sept. 15, 2020)
NIH: NIH Continues to Boost National COVID-19 Testing Capacity (Sept. 2, 2020)
AHA: CMS Releases Guidance for COVID-19 Reporting Requirements for Laboratories and Long-term Care Facilities (Sept. 8, 2020)
HHS: Trump Administration Will Deploy 150 Million Rapid Tests in 2020 (Aug. 27, 2020)
FDA: FDA Approves New Rapid Antigen Test (Aug. 26, 2020)
FDA: FDA Issues An EUA For A New Test To Detect SARS-CoV-2 In Saliva | FAQs (Aug. 25, 2020)
HHS: Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests (August 19, 2020)
FDA: Risk of Inaccurate Results with Thermo Fisher Scientific TaqPath COVID-19 Combo Kit – Letter to Clinical Laboratory Staff and Health Care Providers (Aug. 17, 2020)
CDC: Interim Guidance for Rapid Antigen Testing for SARS-CoV-2 (Aug. 16, 2020)
HHS: HHS Invests in Diagnostic Labs to Expand COVID-19 Testing Capacity in the U.S. (Aug. 13, 2020)
HHS: COVID-19 Testing Plans by State and Jurisdiction
DHSS: Electronic COVID-19 Case Reporting Memo
- MHA: Additional Details
FDA: FDA Posts New Template for At-Home and Over-the-Counter Diagnostic Tests for Use in Non-Lab Settings, Such as Homes, Offices or Schools (July 29, 2020)
HHS: HHS and DOD Invest $7.6M in Hologic to Expand Production of Custom Sample Collection and Processing Consumables for COVID-19 Tests (July 26, 2020)
FDA: Testing Supply Substitution Strategies PowerPoint (July 23, 2020)
FDA: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection (July 24, 2020)
CDC: How to Report COVID-19 Laboratory Data
FDA: FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season (July 2, 2020)
MHA, DHSS: State Testing Strategy Webinar (June 24, 2020) – Recording | PowerPoint
John Hopkins University: COVID-19 Contact Tracing Course
Gilead Sciences: Gilead to Test Inhaled remdesivir (June 22, 2020)
CMS: Medicare FFS Response to the COVID-19 Public Health Emergency (June 19, 2020)
FDA: Certain COVID-19 Serology/Antibody Tests Should Not Be Used (June 19, 2020)
FDA: FAQs on Testing for SARS-CoV-2
CDC: Overview of Testing for SARS-CoV-2
CDC: Testing Strategy for COVID-19 in High-Density Critical Infrastructure Workplaces after a COVID-19 Case Is Identified
FDA: FDA Authorizes COVID-19 Point-Of-Care Test (June 10, 2020)
Johnson & Johnson: Acceleration of COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July (June 10, 2020)
FDA: FDA Authorizes First COVID-19 Diagnostic Test with Next Generation Sequencing (June 9, 2020)
FDA: CURE ID App Lets Clinicians Report Novel Uses of Existing Drugs (June 8, 2020)
FDA: Independent Evaluations of COVID-19 Serological Tests
HHS: HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing (June 4, 2020)
AHA: CMS Issued New Guidance for States on the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group (June 4, 2020)
Missouri DHSS: Health Update Requires Immediate Reporting of Antigen Tests
CDC: Laboratory Alert On Molecular Transport Media And Cyanide Gas (June 2, 2020)
CDC: Interim Guidelines for COVID-19 Antibody Testing (May 23, 2020)
Missouri DHSS: Specimen Collection Supplies Order Form
CMS: Price Transparency: Requirements for Providers to Make Public Cash Prices for COVID-19 Diagnostic Testing
Missouri DHSS: COVID-19 PCR Testing Update
Missouri DHSS: COVID-19 Serological Testing Quick Facts
FDA: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients (May 9, 2020)
FDA: Policy for COVID-19 Tests During the Public Health Emergency (Revised) | Guidance Document (May 2020)
Missouri DHSS: Update – COVID-19 Testing Expansion and Serology Reporting (April 30, 2020)
Missouri DHSS: Update: New Criteria to Guide Evaluation and Laboratory Testing for COVID-19 at the Missouri State Public Health Laboratory (April 22, 2020)
Missouri DHSS: Missouri Testing Sites
Missouri Board of Pharmacy: Statement on COVID-19 Testing (April 13, 2020)
DSS: New Laboratory Codes Updated (April 9, 2020)
DHSS: Guidance for Licensed Pharmacists, COVID-19 Testing, and Immunity under the PREP Act (April 8, 2020)
Missouri DHSS: State Public Health Laboratory requests facilities to use the OpenELIS Portal to submit COVID-19 tests
Missouri DHSS: Health Update on Reporting COVID-19 Cases (April 6, 2020)
CDC: Resources for Hospitals and Healthcare Professionals Preparing for Patients with Suspected or Confirmed COVID-19 (March 25, 2020)
ASPR TRACIE: Training and Technical Assistance (March 16, 2020)

Treatment

There is no specific antiviral treatment recommended for COVID-19 infection. Individuals infected with COVID-19 should receive supportive care to help relieve symptoms. For severe cases, treatment should include care to support vital organ functions.

FDA: FDA Revokes EUA For Bamlanivimab Administered Alone (April 16, 2021)
DHSS: Updated Guidelines for the Anti-SARS-CoV-2 Monoclonal Antibody Treatment of COVID-19 (April 13, 2021)
HHS: Update on COVID-19 Variants and Impact on Bamlanivimab Distribution (March 24, 2021)
DHSS: BinaxNow Antigen Test Kits Reorder Request Online Form
FDA: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 (Feb. 9, 2021)
- Fact Sheet for Health Care Providers EUA of Bamlanivimab
- Fact Sheet for Health Care Providers EUA of Bamlanivimab and Etesevimab
FDA: FDA Alerts Health Care Professionals and Compounders of Potential Risks Associated With the Compounding of Remdesivir Drug Products (Feb. 4, 2021)
HHS: Therapeutics Distribution Locations
DHSS: Standing Order to Administer BinaxNOW Rapid Antigen Test (Jan. 4, 2021)
MHA: Monoclonal Antibodies FAQs (Dec. 15, 2020)
FDA: Investigational COVID-19 Convalescent Plasma: Guidance for Industry (Nov. 16, 2020)
Eli Lilly and Company: Lilly Bamlanivimap Antibody Playbook (November 2020)
Operation Warp Speed: Update: Allocation and Distribution of OWS Therapeutics (Nov. 16, 2020)
FDA: Bamlanivimab Granted EUA For First Antibody Drug Approved | Fact Sheet (Nov. 9, 2020)
HHS: HHS, DOD Collaborate on Plans to Purchase of Lilly Investigational Therapeutic to Treat COVID-19 (Oct. 28, 2020)
NIH: NIH Study Aims to Identify Promising COVID-19 Treatments for Larger Clinical Trials (Oct. 13, 2020)
NIH: NIH Clinical Trial Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir To Treat COVID-19 Begins (Oct. 8, 2020)
FDA: Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing (10/7/20)
AmerisourceBergen: Remdesivir Available For Direct Hospital Purchase (Oct. 1, 2020)
FDA: FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic (August 23, 2020)
- Fact Sheet for Health Care Providers
- Fact Sheet for Patients
NIH: NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring (Aug. 5, 2020)
Mayo Clinic: Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients (June 2020)
FDA: Issues EUAs For Stimulator Device, Ventilator (July 16, 2020)
FDA: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use (June 15, 2020)
HHS: BARDA Funds Two First-In-Human Studies for Regeneron’s COVID-19 Antibody Cocktail (June 15, 2020)
FDA: FDA revokes EUAs for hydroxychloroquine, chloroquine for COVID-19 treatment (June 15, 2020)
FDA: Fact Sheet for Patients and Parent/Caregivers EUA of Remdesivir for COVID-19
CDC: Interim Clinical Guidance for Management of Patients with Confirmed COVID-19 (April 3, 2020)
AACN: COVID-19 Pulmonary, ARDS and Ventilator Resources
SCCM: Emergency Resources for COVID-19
CDC: Interim Guidance for Collection and Submission of Postmortem Specimens from Deceased PUI for COVID-19 (February 2020)

Reporting Deaths

MHA has fielded various questions surrounding reporting COVID-19-related deaths. It is up to the medical provider’s discretion to determine the cause of death. If the medical provider does consider the death to be associated with COVID-19, then the death is to be promptly reported to the Missouri Department of Health and Senior Services.

CDC: Guidance for Certifying Deaths Due to COVID-19 (April 16, 2020)
CDC: COVID-19 Death Data and Reporting Guidance

MHA Contact

Jackie Gatz | Vice President of Safety and Preparedness | 573-893-3700, ext. 1330

View the latest COVID-19 vaccine resources

Government Action

FDA: FDA Extends Expiration Dates For Johnson & Johnson COVID-19 Vaccine (June 10, 2021)
FDA: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic (May 10, 2021)
DHSS: Health Order for COVID-19 Vaccinations of Non-Missouri Residents & Second Dose of a COVID-19 Vaccine, When First Dose Administered Out of State (April 29, 2021)
DHSS: Standing Order for Janssen COVID-19 Vaccine (April 24, 2021)
DHSS: Missouri Pauses J&J COVID-19 Vaccine Administration | Standing Order (April 13, 2021)
DHSS: Revised COVID-19 Vaccine Standing Order Includes EMT-Basics (March 3, 2021)
DHSS: Standing Order for Janssen COVID-19 Vaccine (March 2, 2021)
FDA: Emergency Use Authorization for Janssen COVID-19 Vaccine (Feb. 27, 2021)
- Fact Sheet for Health Care Providers
- Fact Sheet for Recipients and Caregivers
HHS: HHS Permits Retired And Inactive Clinicians To Administer COVID-19 Vaccine (Jan. 27, 2021)
Gov. Parson: Governor Parson Announces Activation of First Tier of Phase 1B of Missouri’s COVID-19 Vaccination Plan (Jan. 14, 2021)
DHSS: COVID-19 Vaccine Standing Order (Jan. 14, 2021)
DHSS: Standing Order for Moderna SARS-CoV-2 Vaccine (Dec. 21, 2020)
DHHS: Standing Order for Pfizer SARS-CoV-2 Vaccine (Dec. 21, 2020)
HHS: Trump Administration Partners with Chain and Independent Community Pharmacies to Increase Access to Future COVID-19 Vaccines (Nov. 12, 2020)
CMS: Trump Administration Acts to Ensure Coverage of Life-Saving COVID-19 Vaccines & Therapeutics (Oct. 28, 2020)
- MHA: Issue Brief: Fourth COVID-19 Interim Final Rule (Oct. 30, 2020)
HHS: Trump Administration Partners with CVS and Walgreens to Provide COVID-19 Vaccine to Protect Vulnerable Americans in Long-Term Care Facilities Nationwide (Oct. 16, 2020)
HHS: Trump Administration Expands Manufacturing Capacity with Cytiva for Components of COVID-19 Vaccines (Oct. 13, 2020)
FDA: EUA for Vaccines to Prevent COVID-19 | Briefing Document (Oct. 6, 2020)
HHS: Administration Announces $200 million from CDC to Jurisdictions for COVID-19 Vaccine Preparedness (Sept. 23, 2020)
Board of Pharmacy: Statement on HHS Expanded Vaccine Authority (Sept. 23, 2020)
HHS: Trump Administration Releases COVID-19 Vaccine Distribution Strategy (Sept. 16, 2020)
HHS: Trump Administration Collaborates with McKesson for COVID-19 Vaccine Distribution (Aug. 14, 2020)
HHS: Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine (Aug. 11, 2020)
HHS: HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses (Aug. 5, 2020)
FDA: Development and Licensure of Vaccines to Prevent COVID-19 (June 30, 2020)
HHS: Agreement to Speed COVID-19 Vaccine Manufacturing (June 2, 2020)
HHS: Trump Administration’s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October (May 21, 2020)

Vaccine Updates

AAP: COVID-19 Vaccines in Children and Adolescents (May 28, 2021)
AJMC: Pause of J&J Vaccine to Continue; ACIP to Reconvene After More Data Collected (April 15, 2021)
Pfizer: Pfizer-Biontech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents (March 31, 2021)
NIH: NIAID Statement on AstraZeneca Vaccine (March 23, 2021)
AstraZeneca: AZD1222 US Phase III Trial Met Primary Efficacy Endpoint in Preventing COVID-19 at Interim Analysis (March 22, 2021
FDA: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine (Feb. 25, 2021)
CDC: Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the U.S. | When to Quarantine (Feb. 11, 2021)
DCI: COVID-19 Vaccine ShowMeVax Reminders (Jan. 19, 2021)
MHA: As Missouri Embarks on its Greatest Logistical Challenge in History, Hospitals are Here to Help (In More Ways Than One) (Jan. 14, 2021)
MHA: Missouri Businesses And Hospitals Partner To Help Increase Awareness Of COVID-19 Vaccination Opportunities (Jan. 14, 2021)
AHA: Letter to HHS on Vaccine Plans (Jan. 7, 2021)
FDA: FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines (Jan. 4, 2021)
FDA: Vaccines and Related Biological Products Advisory Committee December 10, 2020, Meeting Announcement and Materials (Dec. 10, 2020)
FDA: FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine (Dec. 10, 2020)
Moderna: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study (Nov. 16, 2020)
Pfizer: Pfizer and Biontech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis From Phase 3 Study (Nov. 9, 2020)
Moderna: Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (Oct. 22, 2020)
NIH: Investigational COVID-19 Vaccine Well-Tolerated and Generates Immune Response in Older Adults (Sept. 29, 2020)
Johnson & Johnson: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate (Sept. 23, 2020)
Sanofi: Biopharma Leaders Unite to Stand With Science (Sept. 8, 2020)
Business Wire: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study (July 27, 2020)
NIH: Phase 3 clinical trial of investigational vaccine for COVID-19 begins (July 27, 2020)
NIH: Experimental COVID-19 Vaccine Safe, Generates Immune Response (July 16, 2020)

Resources

DHSS: Missouri Plain Language Guide for People with Disabilities, their Families and Caregivers (June 7, 2021)
CDC: Increasing Access to Vaccination Opportunities: COVID-9 Vaccination Upon Discharge from Hospitals, EDs and Urgent Care Facilities (June 4, 2021)
CDC: Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults (May 28, 2021)
CDC: Interim Public Health Recommendations for Fully Vaccinated People (April 27, 2021)
MHA: New Polling Suggests Significant Work Remains To Shift Some Missourians’ Attitudes Toward COVID-19 Vaccination (April 19, 2021)
HHS: COVID-19 Care for Uninsured Individuals – Vaccine Fact Sheets
CMS: COVID-19 Vaccine Resources: What Partners Need to Know Now (March 29, 2021)
DHSS: Just in Time Training Resources for EMT SARS-CoV-2 Vaccinators
CDC: Understanding the Federal Retail Pharmacy Program for COVID-19 Vaccination (March 3, 2021)
Ad Council: The Ad Council and COVID Collaborative Reveal ‘It’s Up To You’ Campaigns to Educate Millions of Americans about COVID-19 Vaccines (Feb. 25, 2021)
DHSS: COVID-19 Vaccinator Guidance (Feb. 19, 2021)
USP: COVID-19 Vaccine Handling Toolkit (January 2021)
DHSS: Missouri Vaccine Navigator
DHSS: COVID-19 Vaccine Shipment Tracker
MHA, DHSS: Hospitals to Support High Throughput Vaccine Distribution in Missouri (Feb. 1, 2021)
DHSS: COVID-19 Vaccine Order Request Form | Missouri’s COVID Vax Operations (Jan. 27, 2021)
MHA: COVID-19 Vaccination Data Requirement Crosswalk and FAQs (Jan. 27, 2021)
DHSS: Missouri Show Me Strong Dashboard
MHA: COVID-19 Vaccine Liability Protections Fact Sheet (Jan. 5, 2021)
CDC: Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States (Dec. 30, 2020)
CDC: COVID-19 Vaccines: Update on Allergic Reactions, Contraindications, and Precautions Webinar (Dec. 30, 2020)
Bloomberg: COVID-19 Vaccine Tracker
MHA: EEOC Vaccine Guidance (Dec. 22, 2020)
Johns Hopkins: Vaccine Tracker
DHSS: COVID-19 Vaccinator FAQs (December 2020)
MHA: Guidance on Safety with Dry Ice (Dec. 14, 2020)
FDA: Fact Sheet for Vaccination Providers (December 2020)
CMS: COVID-19 Vaccines and Monoclonal Antibodies (Dec. 14, 2020)
CDC: Post Vaccine Considerations for Healthcare Personnel (Dec. 13, 2020)
CDC: Post Vaccine Considerations for Long-Term Care Residents (Dec. 13, 2020)
CDC: What Clinicians Need to Know About the Pfizer-BioNTech COVID-19 Vaccine (Dec. 13, 2020)
Board of Nursing: Policy Brief: COVID-19 Vaccine Administration
ACIP: ACIP Provides Interim Recommendations For COVID-19 Vaccine (Dec. 1, 2020)
DHSS: COVID-19 Vaccine Helpful Information (Nov. 24, 2020)
APHA, NAM: COVID-19 Vaccine Update — Development, Approval, Allocation and Distribution in the U.S. (Nov. 18, 2020)
CMS: COVID-19 Vaccine Codes and PC-ACE Software Update (Nov. 12, 2020)
CDC: Engaging in Effective COVID-19 Vaccine Conversations (Nov. 2, 2020)
CMS: COVID-19 Vaccine Toolkits
DHSS: Portal Open For COVID-19 Vaccinator Registration | Tools for Review (Oct. 28, 2020)
DHSS: RFA For Regional COVID-19 Vaccine Implementation Funding (Oct. 27, 2020)
HHS: Guidance for PREP Act Coverage for Qualified Pharmacy Technicians and State-Authorized Pharmacy Interns for Childhood Vaccines, COVID-19 Vaccines, and COVID-19 Testing (Oct. 20, 2020)
CDC: COVID-19 Vaccination Program Provider Agreement
AHA: Summary of Federal Strategy for COVID-19 Vaccine Distribution and How You Can Prepare (Sept. 23, 2020)
National Academies: A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus

MHA Contact

Jill Williams | Vice President of Workforce Initiatives | 573-893-3700, ext. 1395

Staffing

If hospitals need help with temporary staffing during the COVID-19 outbreak, the APS Staffing Program has two crisis response agencies in their program.

ASPR TRACIE: The Work of Hospital Allied and Supportive Care Providers During COVID-19 (April 2021)
MHA: The Impact of COVID-19: 5 Ways Workforce Planning Will Never be the Same (March 9, 2021)
MHA: COVID-19 Surge Staffing and Capacity FAQs (Dec. 4, 2020)
State of Missouri: Online Job Board | Campaign Flyer
MHA: Mitigating Crisis Staff Shortages Fact Sheet (Nov. 12, 2020)
AJN: Practice/Academic Partnerships in the Age of COVID-19 (Oct. 15, 2020)
COVID-19 Surge Staffing Solutions Fact Sheet (Sept. 8, 2020)
NASEM: Crisis Staffing Recommendations (Aug. 4, 2020)
MHA, MONL: Emergency Staffing Considerations Webinar – Recording | PowerPoint
ASPR TRACIE: Healthcare Facility Onboarding Checklist
ASPR TRACIE: Strategies for Managing a Surge in Healthcare Provider Demand
ASPR TRACIE: Managing Healthcare Staffing Shortages During the COVID-19 Pandemic
SCCM: Resource Availability for COVID-19
CDC: Strategies to Mitigate Health Care Personnel Staffing Shortages (April 13, 2020)
ACHE: Making the Shift: Strategies for Leading and Deploying Advanced Practice Providers in Times of Crisis

Employee Well-Being

National Fund: A Trauma-Informed Approach to Workforce (April 2021)
First Responders First, Dr. Lorna Breen Heroes’ Foundation: All in: Well-Being First for Healthcare
The Washington Post: Burned Out by the Pandemic, 3 in 10 Health Care Workers Consider Leaving the Profession (April 22, 2021)
DMH: Coping With COVID-19 Flyer
MHTTC: Responding to COVID-19 Provider Well-Being
MHA: MHA COVID-19 Update: Lessons From the Field in Well-Being (March 31, 2021)
OSHA: OSHA Launches Program to Protect High-Risk Workers from Coronavirus, Focuses on Employers That Retaliate Against Workers with Safety Concerns (March 12, 2021)
HealthWell Foundation: Behavioral Health Grants Available For Health Care Workers Affected By COVID-19
AHA: Well-Being Playbook 2.0: A COVID-19 Resource for Hospital and Health System Leaders (Feb. 18, 2021)
J&J: The Impact of COVID-19 on the Nursing Profession in the U.S.: 2020 Quantitative Survey Summary (Jan. 6, 2021)
First Responder Provider Network
MHA: Clinician Well-Being Webinar Recording (Dec. 10, 2020)
MHA: When Caring Hurts — Implementing a Peer Support Program for Second Victims (Nov. 17, 2020)
AHA: Strategies to Prevent Health Professional Burnout Podcast (Nov. 10, 2020)
MHA: COVID-19 and Mental Health Webinar: Department of Mental Health Resources (Oct. 19, 2020)
MHA: COVID-19 Employee Well-Being Fact Sheet (Sept. 24, 2020)
ASPR TRACIE: Mitigate Absenteeism by Protecting Healthcare Workers’ Psychological Health and Well-being during the COVID-19 Pandemic
ASPR TRACIE: Strategies for Managing a Surge in Healthcare Provider Demand
MU School of Medicine: Office of Clinician Well-Being Resources
NAM: Clinical Well-Being Resources During COVID-19
VA: Managing Healthcare Workers’ Stress Associated with the COVID-19 Virus Outbreak
New York Life, Cigna: Brave of Heart Fund
The Happy MD: Learn the Simple Steps to Stop Physician Burnout

Infection Prevention & Control

CDC: Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection (Interim Guidance) (Aug. 10, 2020)
Missouri DHSS: Expanded Guidance for Critical Infrastructure Personnel Involved in the Provision of Direct Client Care (April 17, 2020)
CDC: Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19 (April 8, 2020)
AHA, CDC: Project Firstline

Other Guidance or Standards

HealthLeaders Exchange: Imagining the Post-COVID Nursing Workforce
Missouri DSS: DSS Eligibility Requirements for Child Care
HHS: COVID-19 Workforce Virtual Toolkit
ASPR TRACIE: COVID-19 Workforce Virtual Toolkit: Resources for Health Care Decision-Makers Responding to COVID-19 Workforce Concerns
MHA: COVID-19 Survey 2.0 Results
New York District Court Invalidates Portions of Paid Leave Rule (Aug. 4, 2020)
SHRM: COVID-19 Workforce Tools and Resources
Employers can immediately provide tax-free qualified disaster payments to employees in connection with COVID-19. FAQs are available.
Missouri DOL: Filing Mass Unemployment Claims
MHA: COVID-19 HR Policy Survey responses (March 19, 2020)
U.S. Department of Labor: Families First Coronavirus Response Act: Questions and Answers
DHSS: Temporary emergency child care facility for preschool and school-age children – Temporary Emergency License Provider Guidanceand Licensing Rules (March 2020)

COVID-19

The resources on this page are continuously updated to reflect the most recent state and federal guidance, as well as Missouri-specific resources.

COVID-19 Dashboards

Latest Updates

Media Library

ROAD TO REOPENING

MHA Contacts

GOVERNMENT ACTION

MHA Contact

ADVOCACY UPDATES

MHA Contact

CLINICAL GUIDANCE

MHA Contacts

DATA & ANALYTICS

MHA Contacts

EDUCATION

MHA Contact

HOSPITAL OPERATIONS

MHA Contacts

LEGAL & REGULATORY

MHA Contacts

PPE & SUPPLY

MHA Contacts

PR & MEDIA

MHA Contact

RURAL

MHA Contacts

SAMPLE POLICIES & FORMS

TESTING, REPORTING & TREATMENT

MHA Contact

VACCINE UPDATES

MHA Contact

WORKFORCE

MHA Contact